Prognostic significance of the CALLY index for mortality among patients with cardiovascular–kidney–metabolic syndrome stages 0–3
Mingshen Lin, Shuaiqing Chen, Jing Ye, Xiaolei Hu · 2025
Read Prognostic significance of the CALLY index for mortality among patients with cardiovascular–kidney–metabolic syndrome stages 0–3 by Mingshen Lin, Shuaiqing Chen, Jing Ye, Xiaolei Hu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12821857.txt.
Description
Mingshen Lin and co-authors test a combined blood index as a death risk marker in a 2025 study. The index joins an inflammation protein, a nutrition protein, and a white cell count, aiming to sum up body state in one cheap number. The team focused on people in the early stages of a heart, kidney, and metabolic syndrome.
National survey data covered nearly ten thousand such adults in the United States. Higher index values linked steadily to lower death rates from all causes and from heart disease. The top third of scores carried about a third less risk than the bottom third. The tie bent into an L shape and held across subgroups. The authors back the index for early risk checks.
Catalog record
| CREATOR | Mingshen Lin, Shuaiqing Chen, Jing Ye, Xiaolei Hu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |